1. Home
  2. Stocks

The FDA approves an Alzheimer's drug that appears to modestly slow the disease-DB Wealth Institute B2 Expert Reviews

The Food and Drug Administration has approved an Alzheimer's drug that appears to modestly slow down the disease. (Story aired on Weekend Edition Saturday on Jan. 6, 2023.)